Benitec Biopharma Limited EPS (Diluted)

EPS (Diluted) of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Diluted) growth rates and interactive chart. Diluted earnings per share (EPS) tells investors how much of a firm's net income was allotted to each share of common stock. It is reported in a company's income statement and is especially informative for businesses with only common stock in their capital structures. Calculated as net income to common divided by the weighted average number of diluted shares outstanding (takes into account potential dilution from options or share issuance).

Highlights and Quick Summary

  • EPS (Diluted) for the quarter ending December 31, 2022 was -0.2 (a -57.45% decrease compared to previous quarter)
  • Year-over-year quarterly EPS (Diluted) decreased by -50.0%
  • Annual EPS (Diluted) for 2022 was -2.23 (a -0.0% decrease from previous year)
  • Annual EPS (Diluted) for 2022 was -2.23 (a -99.65% decrease from previous year)
  • Annual EPS (Diluted) for 2021 was -646.0 (a 19900.0% increase from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Diluted) of Benitec Biopharma Limited

Most recent EPS (Diluted)of BNTC including historical data for past 10 years.

Interactive Chart of EPS (Diluted) of Benitec Biopharma Limited

Benitec Biopharma Limited EPS (Diluted) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.2 -0.47 -0.62 -0.4 -2.23
2021 -117.99 -0.62 -60.0 -164.69 -646.0
2020 -151.26 -2.45 -1.96 -8.1
2019 -2.0 -1.34 3.45
2018 -12.9
2017 -3.3 -7.35
2016 1.2 -38.1

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology